Further support of this was found when applying a module score for the ERBB2 pathway from breast cancer to our data (P = 0.2896, two sided t-test, 17/28 genes present) (43), which did not provide evidence for ERBB2 mediated activity in OCCC (Figure 1C). This evidence concerns the gene ERBB2 and breast carcinoma.